Hagins D, Kumar P, Saag M, Wurapa AK, et al. Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study. J Acquir Immune Defic Syndr 2021;88:86-95.
PMID: 34397746